EurekaMag.com logo
+ Site Statistics
References:
53,517,315
Abstracts:
29,339,501
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Nutritional profile of women with fibrocystic breast disease



Nutritional profile of women with fibrocystic breast disease



International Journal of Epidemiology 22(6): 989-999



The relationship between nutritional factors including eating habits and the presence or absence of fibrocystic breast disease (FBD) with regard to other known risk factors has been investigated in women participating in the National Breast Screening Study (NBSS) in Montreal, Canada. Included in this case-control study were 334 patients with FBD aged 40-59 years at entry to NBSS and 340 controls. Personal and family history was collected from medical records and by interview conducted by a research nurse. Nutritional assessment was done by 24-hour dietary recall, by a food frequency questionnaire and by identification of changes in eating habits 5 years prior to diagnosis. Women > or = 50 years with FBD had higher intake of energy, carbohydrate, fibre, vitamin D, free folacin, calcium, sodium, potassium and magnesium but lower intake of cholesterol than controls. In women < 50 years body mass index and lower protein, niacin and zinc intake, were associated with FBD. In logistic regression analysis, breast pain and education > 12 years were among the most important predictive variables for FBD. The use of oral contraceptives, cholesterol intake > or = 300 mg/day, the proportion of energy provided by fat and saturated fatty acid intake above 10% of energy had a protective effect. The comparison of FBD patients diagnosed by biopsy and those by clinical examination indicated that increasing age had a significant association with the risk of biopsy and a rather weak association with the percentage of energy supplied by fat.

(PDF same-day service: $19.90)

Accession: 002445757

Download citation: RISBibTeXText

PMID: 8144312

DOI: 10.1093/ije/22.6.989



Related references

Intracystic lipidic profile in fibrocystic breast disease. Gynecological Endocrinology 8(4): 287-292, 1994

Critical, morphological, and histopathogenic considerations on fibrocystic breast disease; fibrocystic disease and carcinoma of the breast. Archivio Italiano di Anatomia E Istologia Patologica 24(6): 473-514, 1951

Anovulation and increased androgenic activity as breast cancer risk in women with fibrocystic disease of the breast. Cancer Research 38(9): 3051-3054, 1978

Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease. Journal of Clinical Laboratory Analysis 13(2): 75-81, 1999

Angiogenesis and risk of breast cancer in women with fibrocystic disease. Journal of the National Cancer Institute 86(8): 635-636, 1994

Tamoxifen effects on treatment fibrocystic breast disease in women. Saudi Medical Journal 27(4): 565-566, 2006

Oral contraceptive use and fibrocystic breast disease among pre- and postmenopausal women. American Journal of Epidemiology 120(1): 87-96, 1984

Evaluation of danazol treatment of women with fibrocystic disease of breast. Polski Tygodnik Lekarski 44(32-33): 771-773, 1989

Safety of estrogen therapy for women with fibrocystic breast disease. Clinical Pharmacy 6(9): 683-683, 1987

Estrogen replacement therapy and fibrocystic breast disease in postmenopausal women. American Journal of Epidemiology 121(2): 238-245, 1985

Prolactin and thyrotropin response to trh in premenopausal women with fibrocystic disease of the breast. Hormone Research (Basel) 21(3): 137-144, 1985

Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. Selenium in biology and medicine: proceedings of the Third International Symposium on Selenium in Biology and Medicine held May 27 June 1-1984 Xiangshan Fragrance Hills Hotel Beijing People's Re ic of China: -1121, 1987

Molecular heterogeneity of serum prolactin in women with fibrocystic disease and breast cancer. Journal of Gynaecological Endocrinology 2(1-2): 11-16, 1986

Prolactin dynamics after acute stimulation with trh and domperidone in women with fibrocystic disease of the breast. Angeli, A. Bradlow And L. Dogliotti (ed.). Annals Of The New York Academy Of Sciences, Vol. 464. Endocrinology Of The Breast: Basic And Clinical Aspects; International Congress, Turin, Italy, Sept. 2, 1984. Xvi 640p. The New York Academy Of Sciences: New York, N.y., Usa. Illus. 589-591, 1986

Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. Japanese Journal of Cancer Research 76(5): 374-377, 1985